A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Clinical trial NCT07123090 · RECRUITING

Trial details

NCT number: NCT07123090
Sponsor: Stephanie Berg
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Metastatic Renal Cancer Renal Cell Carcinoma Advanced Clear Cell Renal Cell Carcinoma Kidney Cancer Translocation Renal Cell Carcinoma

Start date: 2025-11-24
Primary completion: 2027-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.